Name | (Z)-4-[(4-{[3-(4-fluorobenzyl)-2,4-dioxo-1,3-thiazolan-5-yliden]methyl}phenoxy)methyl]benzene boronic acid |
---|---|
Synonyms | Boronic acid,B-[4-[[4-[(Z)-[3-[(4-fluorophenyl)Methyl]-2,4-dioxo-5-thiazolidinylidene]Methyl]phenoxy]Methyl]phenyl]- |
Description | HA-155 is a potent and selective autotaxin (ATX) inhibitor with an IC50 of 5.7 nM[1][2][3]. |
---|---|
Related Catalog | |
Target |
IC50: 5.7 nM (ATX)[1] |
In Vitro | HA-155 inhibits ATX by binding to the ATX active site[1]. HA155 completely attenuates the thrombin-mediated increase in platelet-derived LPA in a dose-dependent manner[3]. |
References |
[1]. Albers HM, et al. Chemical Evolution of Autotaxin Inhibitors. Chem Rev. 2012 May 9;112(5):2593-603. |
Molecular Formula | C24H19BFNO5S |
---|---|
Molecular Weight | 463.28600 |
Exact Mass | 463.10600 |
PSA | 112.37000 |
LogP | 3.25890 |
RIDADR | NONH for all modes of transport |
---|